11.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of Eli Lilly antibodies bamlanivimab and […]

11.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue […]

11.03.2021 To the attention of interested persons EMA press release: Reflection paper on the regulatory requirements for vaccines intended to […]

04.03.2021 To the attention of interested persons EMA press release: EMA review of regdanvimab for COVID-19 to support national decisions […]

08.03.2021 To the attention of interested persons EMA press release: EMA issues advice on use of antibody combination (bamlanivimab / […]

04.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of the Sputnik V COVID-19 vaccine […]

04.03.2021 To the attention of interested persons The NAMMDR took note of the existence in the public space of some […]

03.03.2021 To the attention of interested persons EMA press release: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers […]

23.02.2021 To the attention of interested persons EMA press release: EMA starts evaluating use of Veklury in COVID-19 patients not […]

23.02.2021 To the attention of interested persons EMA press release: Precautionary marketing suspension of thalassaemia medicine Zynteglo download document …